237 related articles for article (PubMed ID: 32077340)
1. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present).
Guo J; Zhang Z; Ding K
Expert Opin Ther Pat; 2020 May; 30(5):341-350. PubMed ID: 32077340
[No Abstract] [Full Text] [Related]
2. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
Elkamhawy A; Lu Q; Nada H; Woo J; Quan G; Lee K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207360
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 4-amino-1H-pyrazolo[3,4-d]pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors.
Dong R; Zhou X; Wang M; Li W; Zhang JY; Zheng X; Tang KX; Sun LP
Bioorg Med Chem; 2021 Jan; 29():115876. PubMed ID: 33246255
[TBL] [Abstract][Full Text] [Related]
4. Research progress of DDR1 inhibitors in the treatment of multiple human diseases.
Liu M; Zhang J; Li X; Wang Y
Eur J Med Chem; 2024 Mar; 268():116291. PubMed ID: 38452728
[TBL] [Abstract][Full Text] [Related]
5. Discovery of
Liu L; Zhao L; Yang L; Chai M; Liu Z; Ma N; Wang Y; Wu Q; Guo J; Zhou F; Huang W; Ren X; Wang J; Ding M; Wang Z; Ding K
J Med Chem; 2024 May; 67(10):8043-8059. PubMed ID: 38730324
[TBL] [Abstract][Full Text] [Related]
6. DDR1-targeted therapies: current limitations and future potential.
Wu D; Ding Z; Lu T; Chen Y; Zhang F; Lu S
Drug Discov Today; 2024 May; 29(5):103975. PubMed ID: 38580164
[TBL] [Abstract][Full Text] [Related]
7. Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.
Moll S; Yasui Y; Abed A; Murata T; Shimada H; Maeda A; Fukushima N; Kanamori M; Uhles S; Badi L; Cagarelli T; Formentini I; Drawnel F; Georges G; Bergauer T; Gasser R; Bonfil RD; Fridman R; Richter H; Funk J; Moeller MJ; Chatziantoniou C; Prunotto M
J Transl Med; 2018 Jun; 16(1):148. PubMed ID: 29859097
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo.
Tao J; Zhang M; Wen Z; Wang B; Zhang L; Ou Y; Tang X; Yu X; Jiang Q
Biomed Pharmacother; 2018 Oct; 106():1727-1733. PubMed ID: 30119248
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.
Nada H; Lee K; Gotina L; Pae AN; Elkamhawy A
Comput Biol Med; 2022 Mar; 142():105217. PubMed ID: 35032738
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
Kim HG; Tan L; Weisberg EL; Liu F; Canning P; Choi HG; Ezell SA; Wu H; Zhao Z; Wang J; Mandinova A; Griffin JD; Bullock AN; Liu Q; Lee SW; Gray NS
ACS Chem Biol; 2013 Oct; 8(10):2145-50. PubMed ID: 23899692
[TBL] [Abstract][Full Text] [Related]
11. Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
Li Y; Lu X; Ren X; Ding K
J Med Chem; 2015 Apr; 58(8):3287-301. PubMed ID: 25569119
[TBL] [Abstract][Full Text] [Related]
12. Discoidin Domain Receptor 1 Inhibitors: Advances and Future Directions for Novel Therapeutics with Aid of DNA Encoded Library Screens and Artificial Intelligence.
Sanawar R; Sahayasheela VJ; Sarath P; Dan VM
Mini Rev Med Chem; 2023; 23(15):1507-1513. PubMed ID: 36698236
[TBL] [Abstract][Full Text] [Related]
13. DDR1: A major player in renal diseases.
Dorison A; Chantziantoniou C
Cell Adh Migr; 2018; 12(4):299-304. PubMed ID: 29455614
[TBL] [Abstract][Full Text] [Related]
14. The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease.
Dorison A; Dussaule JC; Chatziantoniou C
Nephron; 2017; 137(3):212-220. PubMed ID: 28743124
[TBL] [Abstract][Full Text] [Related]
15. A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance.
Ambrogio C; Darbo E; Lee SW; Santamaría D
Cell Adh Migr; 2018; 12(4):394-397. PubMed ID: 29505315
[TBL] [Abstract][Full Text] [Related]
16. Design and Synthesis of DDR1 Inhibitors with a Desired Pharmacophore Using Deep Generative Models.
Yoshimori A; Asawa Y; Kawasaki E; Tasaka T; Matsuda S; Sekikawa T; Tanabe S; Neya M; Natsugari H; Kanai C
ChemMedChem; 2021 Mar; 16(6):955-958. PubMed ID: 33289306
[TBL] [Abstract][Full Text] [Related]
17. Two-step release of kinase autoinhibition in discoidin domain receptor 1.
Sammon D; Hohenester E; Leitinger B
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22051-22060. PubMed ID: 32839343
[TBL] [Abstract][Full Text] [Related]
18. Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β
Baltes F; Caspers J; Henze S; Schlesinger M; Bendas G
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668815
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
Bansod S; Saifi MA; Godugu C
Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
Wang Z; Bian H; Bartual SG; Du W; Luo J; Zhao H; Zhang S; Mo C; Zhou Y; Xu Y; Tu Z; Ren X; Lu X; Brekken RA; Yao L; Bullock AN; Su J; Ding K
J Med Chem; 2016 Jun; 59(12):5911-6. PubMed ID: 27219676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]